Wennerberg, Erik et al, Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Science Translational Medicine. 2022 Mar 16;14(636):eabe8195. https://www.science.org/stoken/author-tokens/ST-384/full
Altorki, Nasser K., et al. "The lung microenvironment: an important regulator of tumour growth and metastasis." Nature Reviews Cancer 19.1 (2019): 9-31.
Yao, Zhan, et al. "TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer." Proceedings of the National Academy of Sciences 107.35 (2010): 15535-15540.
Gao, Dingcheng, et al. "Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition." Cancer research 72.6 (2012): 1384-1394.
Altorki, Nasser K., et al. "Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: A single-centre, randomised phase 2 trial." The Lancet Oncology 22.6 (2021): 824-835.
Wennerberg, Erik, et al. "Expression of ART1, an extracellular mono ADP-ribosylase, promotes lung cancer growth and dissemination by limiting tumor infiltration of P2X7R+ CD8+ T cells and CD103+ dendritic cells." JOURNAL FOR IMMUNOTHERAPY OF CANCER. Vol. 7. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND: BMC, 2019.
Chen, Chuang, et al. "ART1, an extracellular ADP-ribosyltransferase, is over-expressed in non-small cell lung cancer and facilitates cancer cell survival by immune-mediated mechanisms." Journal of Thoracic Oncology 11.2 (2016): S44.
https://scholar.google.com/citations?user=fR4OkgkAAAAJ&hl=en&oi=ao